178 related articles for article (PubMed ID: 18940893)
21. The MARCKS protein plays a critical role in phosphatidylinositol 4,5-bisphosphate metabolism and directed cell movement in vascular endothelial cells.
Kalwa H; Michel T
J Biol Chem; 2011 Jan; 286(3):2320-30. PubMed ID: 21097841
[TBL] [Abstract][Full Text] [Related]
22. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.
Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ
J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein.
Masood I; Porter KE; London NJ
Br J Surg; 1997 Apr; 84(4):499-503. PubMed ID: 9112901
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1.
Moss SC; Lightell DJ; Marx SO; Marks AR; Woods TC
J Biol Chem; 2010 Apr; 285(16):11991-7. PubMed ID: 20097763
[TBL] [Abstract][Full Text] [Related]
26. Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo.
Rombouts K; Carloni V; Mello T; Omenetti S; Galastri S; Madiai S; Galli A; Pinzani M
Cancer Lett; 2013 Jun; 333(2):244-52. PubMed ID: 23376641
[TBL] [Abstract][Full Text] [Related]
27. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
28. Toxicological insight from AP-1 silencing study on proliferation, migration, and dedifferentiation of rat vascular smooth muscle cell.
Zhang HW; Zhang T; Shen BZ; Liu M; Liu JR
Cardiovasc Toxicol; 2012 Mar; 12(1):25-38. PubMed ID: 21818553
[TBL] [Abstract][Full Text] [Related]
29. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
[TBL] [Abstract][Full Text] [Related]
30. The antibody specific for myristoylated alanine-rich C kinase substrate phosphorylated by protein kinase C: activation of protein kinase C in smooth muscle cells in human coronary arteries.
Yamamoto H; Matsumura T; Kugiyama K; Oishi Y; Ogata N; Yasue H; Miyamoto E
Arch Biochem Biophys; 1998 Nov; 359(2):151-9. PubMed ID: 9808756
[TBL] [Abstract][Full Text] [Related]
31. Comparison of gene silencing in human vascular cells using small interfering RNAs.
Andersen ND; Monahan TS; Malek JY; Jain M; Daniel S; Caron LD; Pradhan L; Ferran C; Logerfo FW
J Am Coll Surg; 2007 Mar; 204(3):399-408. PubMed ID: 17324773
[TBL] [Abstract][Full Text] [Related]
32. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
[TBL] [Abstract][Full Text] [Related]
33. Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.
Osgood MJ; Hocking KM; Voskresensky IV; Li FD; Komalavilas P; Cheung-Flynn J; Brophy CM
J Vasc Surg; 2014 Jul; 60(1):202-11. PubMed ID: 23911244
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
[TBL] [Abstract][Full Text] [Related]
35. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
36. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
37. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells.
Turner NA; Hall KT; Ball SG; Porter KE
Atherosclerosis; 2007 Jul; 193(1):36-43. PubMed ID: 16979647
[TBL] [Abstract][Full Text] [Related]
38. Desmuslin gene knockdown causes altered expression of phenotype markers and differentiation of saphenous vein smooth muscle cells.
Xiao Y; Huang Z; Yin H; Zhang H; Wang S
J Vasc Surg; 2010 Sep; 52(3):684-90. PubMed ID: 20573469
[TBL] [Abstract][Full Text] [Related]
39. Cyclic stretch upregulates SDF-1alpha/CXCR4 axis in human saphenous vein smooth muscle cells.
Li F; Guo WY; Li WJ; Zhang DX; Lv AL; Luan RH; Liu B; Wang HC
Biochem Biophys Res Commun; 2009 Aug; 386(1):247-51. PubMed ID: 19523923
[TBL] [Abstract][Full Text] [Related]
40. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
